share_log

NexImmune | DEFA14A: Others

NexImmune | DEFA14A: Others

NexImmune | DEFA14A：其他
美股sec公告 ·  07/11 15:13
Moomoo AI 已提取核心信息
NexImmune, Inc. has announced the adjournment of its Special Meeting of Stockholders originally scheduled for July 11, 2024. The meeting has been rescheduled to July 19, 2024, and will be conducted virtually via live webcast. The purpose of the meeting is to seek stockholder approval for the proposed liquidation and dissolution of the company, as detailed in the Proxy Statement issued in June 2024. Stockholders of record as of June 11, 2024, are entitled to vote at the rescheduled meeting. NexImmune has provided various options for stockholders to submit their proxy votes, including over the Internet, by telephone, by mail, or during the live webcast of the meeting. Votes can be submitted until 11:59 p.m. Eastern Time on July 18, 2024. The company has engaged Laurel Hill Advisory Group, LLC to assist stockholders with voting and inquiries. NexImmune's management has expressed appreciation for stockholders' prompt attention and continued confidence.
NexImmune, Inc. has announced the adjournment of its Special Meeting of Stockholders originally scheduled for July 11, 2024. The meeting has been rescheduled to July 19, 2024, and will be conducted virtually via live webcast. The purpose of the meeting is to seek stockholder approval for the proposed liquidation and dissolution of the company, as detailed in the Proxy Statement issued in June 2024. Stockholders of record as of June 11, 2024, are entitled to vote at the rescheduled meeting. NexImmune has provided various options for stockholders to submit their proxy votes, including over the Internet, by telephone, by mail, or during the live webcast of the meeting. Votes can be submitted until 11:59 p.m. Eastern Time on July 18, 2024. The company has engaged Laurel Hill Advisory Group, LLC to assist stockholders with voting and inquiries. NexImmune's management has expressed appreciation for stockholders' prompt attention and continued confidence.
NexImmune，Inc.宣布推迟原定于2024年7月11日举行的特别股东大会。该会议已经重新安排于2024年7月19日通过网络直播方式进行。本次会议的目的是寻求股东批准公司的清算和解散，详见2024年6月发布的代理声明。截至2024年6月11日，注册股东有权在重新安排的会议上表决。NexImmune为股东们提供了各种期权来提交他们的代理投票，包括在互联网上提供，通过电话，通过邮寄或在会议的网络直播期间。投票可在2024年7月18日晚上11:59 Eastern Time前提交。该公司已聘请Laurel Hill Advisory Group，LLC协助股东投票和查询。NexImmune的管理层感谢股东们的迅速关注和持续信任。
NexImmune，Inc.宣布推迟原定于2024年7月11日举行的特别股东大会。该会议已经重新安排于2024年7月19日通过网络直播方式进行。本次会议的目的是寻求股东批准公司的清算和解散，详见2024年6月发布的代理声明。截至2024年6月11日，注册股东有权在重新安排的会议上表决。NexImmune为股东们提供了各种期权来提交他们的代理投票，包括在互联网上提供，通过电话，通过邮寄或在会议的网络直播期间。投票可在2024年7月18日晚上11:59 Eastern Time前提交。该公司已聘请Laurel Hill Advisory Group，LLC协助股东投票和查询。NexImmune的管理层感谢股东们的迅速关注和持续信任。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息